News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neurosearch A/S (NEUR.CO) Closes the Sale of Huntexil® to Teva Pharmaceutical Industries Limited (TEVA) and Adjusts the Expectations to the Full-Year Result


10/25/2012 9:40:28 AM

Today, NeuroSearch A/S (OMX: NEUR) closed the asset transfer agreement with Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) concerning the sale of the Huntexil® project to Teva as described in announcement no. 21-12 of 27 September 2012. The agreement was approved by NeuroSearch shareholders at the Extraordinary General Meeting, which was held on 23 October 2012.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES